Stock-Based Compensation (Stock-Settled Stock Appreciation Rights Activity) (Details) (Stock Settled Stock Appreciation Rights SARS [Member], USD $) In Thousands, except Share data, unless otherwise specified	6 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Stock Settled Stock Appreciation Rights SARS [Member]
Number of Rights
Number of Rights, Outstanding at beginning of period	374,000
Number of Rights, Exercised	(7,000)
Number of Rights, Granted	2,000	0
Number of Rights, Forfeited	0
Number of Rights, Outstanding at end of period	369,000
Number of Rights, Exercisable and vested at end of period	105,000
Number of Rights, Vested and expected to vest at end of period	360,000
Weighted Average Exercise Price
Weighted Average Exercise Price, Outstanding at beginning of period	$ 66.42
Weighted Average Exercise Price, Exercised	$ 61.48
Weighted Average Exercise Price, Granted	$ 79.78
Weighted Average Exercise Price, Forfeited	$ 0.00
Weighted Average Exercise Price, Outstanding at end of period	$ 66.57
Weighted Average Exercise Price, Exercisable and vested at end of period	$ 60.85
Weighted Average Exercise Price, Vested and expected to vest at end of period	$ 66.57
Weighted Average Remaining Contractual Life in Years, Outstanding at end of period	3 years 11 days
Weighted Average Remaining Contractual Life in Years, Exercisable and vested at end of period	1 year 11 months 12 days
Weighted Average Remaining Contractual Life in Years, Vested and expected to vest at end of period	3 years 11 days
Aggregate Intrinsic Value, Outstanding at end of period	$ 7,966
Aggregate Intrinsic Value, Exercisable and vested at end of period	2,865
Aggregate Intrinsic Value, Vested and expected to vest at end of period	$ 7,770